基于初诊时功能影像学标志物对早期霍奇金淋巴瘤患者重新分类
该研究回顾性分析了2003至2013年在本机构治疗的267例I-II期霍奇金淋巴瘤患者的治疗前PET-CT,通过手动勾画和阈值分割(SUV≥2.5)提取代谢肿瘤体积(MTV)和总病灶糖酵解(TLG),发现MTVt和TLGt与无进展生存高度相关,并可使早期不良霍奇金淋巴瘤患者重新分层为低危和高危。
要点
- 在267例早期霍奇金淋巴瘤患者中,MTVt和TLGt与无进展生存高度相关。
- MTVt和TLGt的80百分位截断值分别为268和1703。
- MTV和TLG使早期不良霍奇金淋巴瘤患者可重新分层为低危和高危。
核心结论
- MTV和TLG提供了潜在的肿瘤负荷测量方法,有助于早期不良霍奇金淋巴瘤患者的风险分层。
研究设计与样本
- 回顾性分析2003至2013年在本机构治疗的267例I-II期霍奇金淋巴瘤患者的治疗前PET-CT扫描。
主要发现
- 中位随访4.96年,267例患者中27例诊断为复发或难治性疾病,12例死亡。
- MTVt和TLGt与无进展生存高度相关,80百分位截断值分别为268和1703。
- 考虑MTV和TLG使早期不良霍奇金淋巴瘤患者可重新分层为低危和高危疾病。
关键数值与推荐
- 疾病在化疗前PET-CT扫描上通过两种方法勾画:手动勾画和将轮廓进行亚阈值分割以获得标准化摄取值≥2.5的肿瘤体积。
- MTV和TLG从阈值体积(MTVt、TLGt)和手动勾画的软组织体积中提取。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The presence of bulky disease in Hodgkin lymphoma (HL), traditionally defined with a 1-dimensional measurement, can change a patient's risk grouping and thus the treatment approach. We hypothesized that 3-dimensional measurements of disease burden obtained from baseline 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) scans, such as metabolic tumor volume (MTV) and total lesion glycolysis (TLG), would more accurately risk-stratify patients. To test this hypothesis, we reviewed pretreatment PET-CT scans of patients with stage I-II HL treated at our institution between 2003 and 2013. Disease was delineated on prechemotherapy PET-CT scans by 2 methods: (1) manual contouring and (2) subthresholding of these contours to give the tumor volume with standardized uptake value ≥2.5. MTV and TLG were extracted from the threshold volumes (MTVt, TLGt) and from the manually contoured soft-tissue volumes. At a median follow-up of 4.96 years for the 267 patients evaluated, 27 patients were diagnosed with relapsed or refractory disease and 12 died. Both MTVt and TLGt were highly correlated with freedom from progression and were dichotomized with 80th percentile cutoff values of 268 and 1703, respectively. Consideration of MTV and TLG enabled restratification of early unfavorable HL patients as having low- and high-risk disease. We conclude that MTV and TLG provide a potential measure of tumor burden to aid in risk stratification of early unfavorable HL patients.
引用
- Akhtari M, Milgrom SA, Pinnix CC, et al. Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood. 2017. PMID: 29038339. doi:10.1182/blood-2017-04-773838
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。